DE1212082B - Process for the preparation of 3, 11-Dioxo-20-tert-amino-20-alkyl-4-pregnenverbindungen and salts thereof - Google Patents
Process for the preparation of 3, 11-Dioxo-20-tert-amino-20-alkyl-4-pregnenverbindungen and salts thereofInfo
- Publication number
- DE1212082B DE1212082B DER35992A DER0035992A DE1212082B DE 1212082 B DE1212082 B DE 1212082B DE R35992 A DER35992 A DE R35992A DE R0035992 A DER0035992 A DE R0035992A DE 1212082 B DE1212082 B DE 1212082B
- Authority
- DE
- Germany
- Prior art keywords
- methyl
- dioxo
- ecm
- dimethylamino
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000003839 salts Chemical class 0.000 title claims description 12
- 238000000034 method Methods 0.000 title claims description 9
- 238000002360 preparation method Methods 0.000 title claims description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 24
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 24
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 239000000047 product Substances 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- SUPOKHOQAKXOHJ-BYZMTCBYSA-N (8s,9s,10r,13r,14s,17s)-17-ethyl-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthrene Chemical compound C1CC2=CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](CC)[C@@]1(C)CC2 SUPOKHOQAKXOHJ-BYZMTCBYSA-N 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 7
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims description 6
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 6
- -1 alkyl radicals Chemical class 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- 239000002244 precipitate Substances 0.000 claims description 5
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 4
- 239000013078 crystal Substances 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 229910052740 iodine Inorganic materials 0.000 claims description 4
- 239000011630 iodine Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 238000005893 bromination reaction Methods 0.000 claims description 3
- 229910000042 hydrogen bromide Inorganic materials 0.000 claims description 3
- 150000007975 iminium salts Chemical class 0.000 claims description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 claims description 3
- 125000000468 ketone group Chemical group 0.000 claims description 3
- NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 claims description 3
- 239000012299 nitrogen atmosphere Substances 0.000 claims description 3
- 150000001350 alkyl halides Chemical class 0.000 claims description 2
- 150000004791 alkyl magnesium halides Chemical class 0.000 claims description 2
- 230000031709 bromination Effects 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- GRWVQDDAKZFPFI-UHFFFAOYSA-H chromium(III) sulfate Chemical compound [Cr+3].[Cr+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRWVQDDAKZFPFI-UHFFFAOYSA-H 0.000 claims description 2
- 229940126214 compound 3 Drugs 0.000 claims description 2
- 230000008030 elimination Effects 0.000 claims description 2
- 238000003379 elimination reaction Methods 0.000 claims description 2
- 230000007062 hydrolysis Effects 0.000 claims description 2
- 238000006460 hydrolysis reaction Methods 0.000 claims description 2
- 239000007800 oxidant agent Substances 0.000 claims description 2
- 150000003141 primary amines Chemical class 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 3
- 238000007269 dehydrobromination reaction Methods 0.000 claims 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 claims 2
- 239000011707 mineral Substances 0.000 claims 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- MAZMPHFJWNZKEQ-UHFFFAOYSA-L dilithium hydrogen carbonate bromide Chemical compound C([O-])(O)=O.[Li+].[Br-].[Li+] MAZMPHFJWNZKEQ-UHFFFAOYSA-L 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 claims 1
- 229910052808 lithium carbonate Inorganic materials 0.000 claims 1
- 238000002844 melting Methods 0.000 claims 1
- 230000008018 melting Effects 0.000 claims 1
- 150000007524 organic acids Chemical class 0.000 claims 1
- 239000011541 reaction mixture Substances 0.000 claims 1
- 239000007858 starting material Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 238000010792 warming Methods 0.000 claims 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- ATHHXGZTWNVVOU-UHFFFAOYSA-N N-methylformamide Chemical compound CNC=O ATHHXGZTWNVVOU-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- SMBQBQBNOXIFSF-UHFFFAOYSA-N dilithium Chemical compound [Li][Li] SMBQBQBNOXIFSF-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- LBAQSKZHMLAFHH-UHFFFAOYSA-N ethoxyethane;hydron;chloride Chemical compound Cl.CCOCC LBAQSKZHMLAFHH-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- KPJPHPFMCOKUMW-UHFFFAOYSA-N iodomethane Chemical compound I[CH2] KPJPHPFMCOKUMW-UHFFFAOYSA-N 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
DEUTSCHESGERMAN
PATENTAMTPATENT OFFICE
AUSLEGESCHRIFTEDITORIAL
Int. Cl.:Int. Cl .:
C07cC07c
Deutschem.: 12 ο-25/05German: 12 ο-25/05
Nummer: 1212 082Number: 1212 082
Aktenzeichen: R 35992IV b/12 οFile number: R 35992IV b / 12 ο
Anmeldetag: 27. August 1963 Filing date: August 27, 1963
Auslegetag: 10. März 1966Opening day: March 10, 1966
Die Erfindung betrifft ein Verfahren zur Herstellung von neuen SJl-Dioxo^O-tert.-amino-^O-alkyl-4-pregnenverbindungen der allgemeinen Formel IThe invention relates to a process for the preparation of new SJl-Dioxo ^ O-tert-amino- ^ O-alkyl-4-pregnenverbindungen of the general formula I.
CH3 CH 3
C —Ν:C --Ν:
RiRi
in Form der freien Basen oder entsprechender Salze.in the form of the free bases or corresponding salts.
In dieser Formel bedeuten R und R1 niedere Alkylreste, Aryl- oder Aralkylreste, und R2 bedeutet einen Alkylrest mit 1 bis 4 Kohlenstoffatomen.In this formula, R and R 1 denote lower alkyl radicals, aryl or aralkyl radicals, and R 2 denotes an alkyl radical having 1 to 4 carbon atoms.
Die nach dem erfindungsgemäßen Verfahren erhaltenen neuen Produkte besitzen interessante physiologische Eigenschaften, vor allem eine spasmolytische, vasodilatatorische und insbesondere eine coronardilatorische Wirkung.The new products obtained by the process according to the invention have interesting physiological properties Properties, especially spasmolytic, vasodilatory and especially coronary dilatory Effect.
Unter diesen Verbindungen ist 3,ll-Dioxo-20-methyl-20-dimethylamino-J4-pregnen von besonderem Interesse.Among these compounds, 3,1-dioxo-20-methyl-20-dimethylamino-J 4 -pregnene is of particular interest.
Die angewandte Dosierung dieser Verbindungen bewegt sich zwischen 5 und 20 mg je Dosis und 10 bis 100 mg je Tag beim Erwachsenen, je nach der Art der Verabreichung.The applied dosage of these compounds ranges between 5 and 20 mg per dose and 10 to 100 mg per day for adults, depending on the route of administration.
Das erfindungsgemäße Verfahren zur Herstellung der Verbindungen der allgemeinen Formel I ist dadurch
gekennzeichnet, daß man in an sich bekannter Weise ein primäres Amin der Formel NH2R, worin
R die vorstehend angegebene Bedeutung hat, mit einem in 3- und 11-Stellung oxygenierten 20-Oxo-5/9-pregnan,
dessen etwa vorhandene andere Ketofunktionen man vorher durch Bildung eines cyclischen
Ketals geschützt hat, umsetzt, das erhaltene 20-Iminoderivat durch Behandlung mit einem niederen Alkylhalogenid
oder einem Aryl- oder Aralkylhalogenid der Formel Hai—R1, worin Hai ein Halogenatom darstellt
und R1 die vorstehend angegebene Bedeutung hat, in das ternäre Iminiumsalz überführt, das erhaltene
Salz mit einem Alkylmagnesiumhalogenid der Formel Hai—MgR2, worin Hai ein Halogenatom bedeutet
und R2 die vorstehend angegebene Bedeutung hat, umsetzt, das erhaltene 20-Alkyl-20-tert.-aminosteroid
nach vorübergehender Salzbildung isoliert und vorhandene geschützte Ketofunktionen gegebenenfalls
durch Hydrolyse freisetzt, in der erhaltenen Ver-Verfahren zur Herstellung von 3,11-Dioxo-20-tert.-amino-20-alkyl-4-pregnenverbindungen
und Salzen derselbenThe process according to the invention for the preparation of the compounds of general formula I is characterized in that, in a manner known per se, a primary amine of the formula NH 2 R, in which R has the meaning given above, with a 20 oxygenated in the 3- and 11-positions -Oxo-5/9-pregnane, the other keto functions which may be present, have previously been protected by the formation of a cyclic ketal, and the 20-imino derivative obtained is reacted by treatment with a lower alkyl halide or an aryl or aralkyl halide of the formula Hai-R 1 , wherein Hai represents a halogen atom and R 1 has the meaning given above, converted into the ternary iminium salt, the salt obtained with an alkylmagnesium halide of the formula Hai — MgR 2 , wherein Hai is a halogen atom and R 2 has the meaning given above, which 20-alkyl-20-tert-aminosteroid obtained isolated after temporary salt formation and protected keto functions, if appropriate, dur ch hydrolysis is released, in the resulting process for the preparation of 3,11-dioxo-20-tert-amino-20-alkyl-4-pregnenverbindungen
and salts thereof
Anmelder:Applicant:
Roussel-Uclaf, ParisRoussel-Uclaf, Paris
Vertreter:Representative:
Dr. F. Zumstein,Dr. F. Zumstein,
Dipl.-Chem. Dr. rer. nat. E. AssmannDipl.-Chem. Dr. rer. nat. E. Assmann
und Dipl.-Chem. Dr. R. Koenigsberger,and Dipl.-Chem. Dr. R. Koenigsberger,
Patentanwälte, München 2, Bräuhausstr. 4Patent Attorneys, Munich 2, Bräuhausstr. 4th
Als Erfinder benannt:
Dr.-Ing. Daniel Bertin, Montrouge, Seme;
Dr. Lucien Nedelec, Clichy-sur-Bois,
Seine-et-Oise (Frankreich)Named as inventor:
Dr.-Ing. Daniel Bertin, Montrouge, Seme;
Dr. Lucien Nedelec, Clichy-sur-Bois,
Seine-et-Oise (France)
Beanspruchte Priorität:
Frankreich vom 27. August 1962 (907 856),
vom 3. Mai 1963 (933 624)Claimed priority:
France of August 27, 1962 (907 856),
of May 3, 1963 (933 624)
bindung vorhandene freie Hydroxylfunktionen in 3- und 11-Stellung oxydiert und durch 4-Bromierung und anschließende Dehydrobromierung eine Doppelbindung in 4(5)-Stellung einführt und gegebenenfalls die erhaltene Verbindung in ein Salz einer Mineralsäure oder einer organischen Säure überführt.bond existing free hydroxyl functions in the 3- and 11-positions and oxidized by 4-bromination and subsequent dehydrobromination introduces a double bond in the 4 (5) position and optionally the compound obtained is converted into a salt of a mineral acid or an organic acid.
Zur Herstellung der oben angegebenen Verbindung 3,ll-Dioxo-20-methyl-20-dimethylamino-zl4-pregnen arbeitet man wie folgt:To prepare the compound 3, ll-dioxo-20-methyl-20-dimethylamino-zl 4 -pregnen given above, the procedure is as follows:
Man stellt zuerst 3«,ll/?-Dihydroxy-20-methyl-20-dimethylamino-5j3-pregnan her, indem man 3«-Acetoxy-Ilß-hydroxy-20-oxo-5j3-pregnan mit Methylamin in Gegenwart von Natriummethylat umsetzt, das erhaltene 3«,ll/3-Dihydroxy-20-methylimino-5/3-pregnan durchBehandlungmit Methyljodid in das entsprechende Jodmethylat überführt, letztere Verbindung mit Methylmagnesiumbromid reagieren läßt und so das 3«,ll/?-Dihydroxy-20-methyl-20-dimethylamino-5^-pregnan erhält. Dann stellt man daraus das 3,ll-Dioxo-20-methyl-20-dimethylamino-5/?-pregnan her, indem man das erhaltene 3&,llß-Dihydroxy-20-methyl-20-dimethylamino-5/3-pregnan der Einwirkung eines energischen Oxydationsmittels, wie Chromschwefelsäure, unterwirft. First one prepares 3 ", ll /? - dihydroxy-20-methyl-20-dimethylamino-5j3-pregnan by adding 3'-acetoxy-ILß-hydroxy-20-oxo-5j3-pregnane reacted with methylamine in the presence of sodium methylate, the resulting 3 ", ll / 3-dihydroxy-20-methylimino-5/3-pregnane converted into the corresponding iodine methylate by treatment with methyl iodide, the latter compound with methyl magnesium bromide lets react and so the 3 ", ll /? - dihydroxy-20-methyl-20-dimethylamino-5 ^ -pregnane receives. Then the 3, ll-dioxo-20-methyl-20-dimethylamino-5 /? - pregnane is made from it by processing the obtained 3 &, llß-dihydroxy-20-methyl-20-dimethylamino-5/3-pregnane subjected to the action of an energetic oxidizing agent, such as chromosulfuric acid.
609 537/440609 537/440
3 43 4
Zur Überführung des S^l-Dioxo-^O-methyl^O-di- Das Produkt wurde in der Literatur bisher nochTo transfer the S ^ l-Dioxo- ^ O-methyl ^ O-di- The product has been in the literature so far
methylamino-5/i-pregnans in das gewünschte 3,11-Di- nicht beschrieben.
oxo-20-methyl-20-dimethylamino-44-pregnen wird diemethylamino-5 / i-pregnans into the desired 3,11-di- not described.
oxo-20-methyl-20-dimethylamino-4 4 -pregnen is the
Doppelbindung in 4(5)-Stellung durch Bromieren in Stufe C:Double bond in 4 (5) position by bromination in stage C:
Essigsäure und Bromwasserstoffabspaltung mit dem 5 3a5l¥.Dihydroxy.20-methyl-20-dimethylamino- Acetic acid and elimination of hydrogen bromide with the 5 3 a5l ¥. Dihydroxy . 2 0-methyl-20-dimethylamino
Salzpaar Lithiumbromid—Lithiumcarbonat in Di- co Salt pair lithium-lithium in di- co
methylformamid eingeführt. ^-pregnanmethylformamide introduced. ^ -pregnan
Das folgende Beispiel erläutert das Verfahren der Man gibt 330 ecm einer 3,42 molaren ätherischenThe following example illustrates the procedure of giving 330 ecm of a 3.42 molar essential
Erfindung. Lösung von Methylmagnesiumbromid in 470 ecmInvention. Solution of methyl magnesium bromide in 470 ecm
Beispiell 10 Tetrahydrofuran, fügt langsam 31,25 g des in Stufe BFor example 10 tetrahydrofuran, slowly add 31.25 g of the in step B
erhaltenen Jodmethylats von 3a,llß-Dihydroxy-obtained iodine methylate of 3a, llß-dihydroxy
Herstellung von 3,ll-Dioxo-20-methyl-20-dimethyl- 20-methylimino-5/?-pregnan zu, bringt 16 StundenProduction of 3,1-dioxo-20-methyl-20-dimethyl-20-methylimino-5 /? - pregnane takes 16 hours
amino-zl4-pregnen unter Stickstoffatmosphäre zum Rückfluß und gießtamino-zl 4 -pregnen under a nitrogen atmosphere to reflux and pour
dann in ein Gemisch von 3000 ecm Wasser, 300 gthen in a mixture of 3000 ecm of water, 300 g
Stufe Ä: 1S Ammoniumchlorid und 450 ecm konzentriertem Am-Level Ä: 1 S ammonium chloride and 450 ecm concentrated am-
3«,ll/3-Dihydroxy-20-methylimino-5yS-pregnan moniak. „..„.,.3 ", ll / 3-dihydroxy-20-methylimino-5yS-pregnan moniak. "..".,.
r 3 J * ' F ö Man rührt 30 bis 40 Minuten und extrahiert mit r 3 J * ' F ö The mixture is stirred for 30 to 40 minutes and extracted with
Man kühlt eine Lösung von 250 ecm Monomethyl- einer Mischung von Benzol und Äther (1:1). Man amin in 300 ecm Methanol auf 00C ab und fügt 43 g wäscht mit Wasser, trocknet über Magnesiumsulfat 3a-Acetoxy-llß-hydroxy-20-oxo-5|8-pregnan und 20 g 20 und verdampft im Vakuum zur Trockne. Man löst Natriummethylat zu. Man rührt das Reaktions- das erhaltene Produkt in 500 ecm Äther und leitet gemisch eine Nacht bei 1200C, kühlt auf 00C ab, durch die Lösung einen Strom von Chlorwasserstoffsaugt ab und wäscht den Niederschlag mit eisgekühltem gas bis zur sauren Reaktion. Man rührt 30 Minuten, Methanol, dann mit Wasser und trocknet im Vakuum. saugt ab und versetzt mit 250 ecm wäßrigem Äthanol Man erhält so 12,51 g 3«,ll^-Dihydroxy-20-methyl- 25 und dann mit 500 ecm Wasser und läßt die Mischung imino-5/J-pregnan. Die eingeengten methanolischen über Nacht bei Zimmertemperatur unter Stickstoff-Mutterlaugen liefern noch 11,97 g, was eine Gesamt- atmosphäre stehen.A solution of 250 ecm monomethyl- a mixture of benzene and ether (1: 1) is cooled. It amine in 300 cc methanol at 0 0 C and adds 43 g washed with water, dried over magnesium sulfate, 3a-acetoxy-LLSs-hydroxy-20-oxo-5 | 8-pregnane and 20 g of 20 and evaporated in vacuo to dryness. Sodium methylate is dissolved. Stir the reaction, the obtained product in 500 cc of ether and forwards mixture overnight at 120 0 C, cooled to 0 0 C., through the solution for a stream of hydrogen chloride filtered off and the precipitate is washed with ice-cooled gas until acidic. The mixture is stirred for 30 minutes, methanol, then with water and dried in vacuo. Sucked off and mixed with 250 ecm of aqueous ethanol. This gives 12.51 g of 3 ", ll ^ -dihydroxy-20-methyl-25 and then with 500 ecm of water, and the mixture is left imino-5 / I-pregnan. The concentrated methanolic solution overnight at room temperature under nitrogen mother liquors still yield 11.97 g, which is a total atmosphere.
ausbeute von 24,48 g ergibt (F. =234°C). [«]o° Man wäscht mit Äther und mit Petroläther undyield of 24.48 g results (m.p. = 234 ° C). [«] O ° One washes with ether and with petroleum ether and
= +79,l±l° (C-I0I0, Chloroform). Ausbeute versetzt mit 40ecm Natronlauge. Man saugt den= + 79.1 ± 1 ° (CI 0 I 0 , chloroform). 40 cm of sodium hydroxide solution are added to the yield. One sucks the
= 62 °/0. 3o gebildeten Niederschlag ab und extrahiert die wäßrige= 62 ° / 0 . 3o formed precipitate and extracted the aqueous
Die Mutterlaugen der zweiten Ausbeute ergibt nach Lösung mit einer Mischung von Benzol und Äther (1:1).The mother liquors of the second crop are obtained after dissolution with a mixture of benzene and ether (1: 1).
Verdünnen mit Wasser 13 g 3a,ll/3-Dihydroxy-20-oxo- Man erhält 19,18 g rohes SaAlß-Dihydroxy^O-me-Dilute with water 13 g of 3a, ll / 3-dihydroxy-20-oxo-19.18 g of crude SaAlß-dihydroxy ^ O-me-
5j5-pregnan (F. = 209 bis 21O0C). thyl^O-dimethylamino-S^-pregnan.5J5-pregnane (F. = 209 to 21O 0 C). thyl ^ O-dimethylamino-S ^ -pregnane.
Das 3a,ll^-Dihydroxy-20-methylimino-5jS-pregnan Das durch Umkristallisieren aus IsopropylätherThe 3a, ll ^ -dihydroxy-20-methylimino-5jS-pregnane Das by recrystallization from isopropyl ether
ergibt sich in Form von farblosen Kristallen, die in 35 gereinigte Produkt zeigt die folgenden Konstanten:results in the form of colorless crystals, the purified product in 35 shows the following constants:
Alkohol und Äther wenig löslich, in Chloroform F. = etwa 15O0C, [«]!? =+39,5 ± 1° (c = l%,Alcohol and ether, slightly soluble in chloroform F. = about 15O 0 C, [ «] !? = + 39.5 ± 1 ° (c = l%,
löslich und in Wasser unlöslich sind. Äthanol).are soluble and insoluble in water. Ethanol).
r< τι r-> -KT ιλι e.n ^as Produkt ergibt sich in Form von farblosen r < τι r-> -KT ιλι en ^ as product results in the form of colorless
Analyse: C22H37U2N = 34/,53. Kristallen, die in Alkohol, Äther, Aceton, Benzol undAnalysis: C 22 H 37 U 2 N = 34 /, 53. Crystals found in alcohol, ether, acetone, and benzene
Berechnet ... N 4,03 %; 40 Chloroform löslich sind.Calculated ... N 4.03%; 40 chloroform are soluble.
gefunden ... N 4,4«/.found ... N 4.4 «/.
Das Produkt wurde in der Literatur bisher noch Berechnet ... C76,34%, H 11,47%, N3,71%;The product has so far been calculated in the literature ... C76.34%, H 11.47%, N3.71%;
nicht beschrieben. gefunden ... C76,5%, H 11,3%, N3,9%.not described. found ... C76.5%, H 11.3%, N3.9%.
Stufe B- ^as Pr0CUIkt wurde in der Literatur bisher nochLevel B- ^ as P r0CUI kt has hitherto been in the literature
nicht beschrieben.not described.
Jodmethylat von Sajllß-Dihydroxy^O-methyh'mino- Man erhält das Hydrochlorid, indem man eineIodomethylate of Sajllß-Dihydroxy ^ O-methyh'mino- The hydrochloride is obtained by adding a
5/J-pregnan Lösung des Produkts in Äthylacetat mit 1,45 normalem5 / J-pregnan solution of the product in ethyl acetate with 1.45 normal
50 salzsaurem Äther behandelt (F. = etwa 3000C).
Man gibt 23,39 g 3a,ll|ö-Dihydroxy-20-methyl-50 hydrochloric acid ether treated (F. = about 300 0 C).
23.39 g of 3a, ll | ö-dihydroxy-20-methyl-
imino-5/?-pregnan in 300 ecm Chloroform, destilliert Stufe D:imino-5 /? - pregnan in 300 ecm chloroform, distilled stage D:
30 ecm Lösungsmittel ab, setzt 70 ecm Methyljodid Herstellung von30 ecm solvent off, 70 ecm methyl iodide continues production of
zu und bringt unter Stickstoffatmosphäre 2V2 Stunden s^l-Dioxo^O-methyl^O-dimethylamino^-pregnanand brings 2V 2 hours s ^ l-Dioxo ^ O-methyl ^ O-dimethylamino ^ -pregnane under a nitrogen atmosphere
zum Ruckfluß. 55 r to the reflux. 55 r
Man kühlt, saugt den Niederschlag ab, wäscht Man löst 14,6 g des in der Stufe C erhaltenen rohenIt is cooled, the precipitate is filtered off with suction and washed. 14.6 g of the crude obtained in stage C are dissolved
mit Chloroform und mit Äther und trocknet im 3a,ll/3 - Dihydroxy - 20 - methyl - 20 - dimethylamino-with chloroform and with ether and dries in 3a, ll / 3 - dihydroxy - 20 - methyl - 20 - dimethylamino-
Trockenschrank bei 8O0C. Man erhält 31,25 g Jod- 5/3-pregnans in 220 ecm Essigsäure und versetzt unterOven at 8O 0 C. This gives 31.25 g of iodine 5/3-pregnane in 220 cc of acetic acid and added with
methylat von 3oi,lljö-Dihydroxy-20-methylimino- Rühren, während man die Temperatur auf 20°Cmethylate of 3oi, lljö-dihydroxy-20-methylimino- Stir while the temperature is raised to 20.degree
5/?-pregnan (F. > 300° C), was einer Ausbeute von 60 hält, mit 26,5 ecm einer Lösung von 135 g Chrom-5 /? - pregnane (m.p.> 300 ° C), which holds a yield of 60, with 26.5 ecm of a solution of 135 g of chromium
95 % entspricht. Säureanhydrid und 115 ecm konzentrierter Schwefel-95% corresponds. Acid anhydride and 115 ecm concentrated sulfur
Das Produkt ist in Wasser und Alkohol wenig säure, die man mit Wasser auf 500 ecm aufgefülltThe product is not very acidic in water and alcohol, which is made up to 500 ecm with water
löslich und in Äther, Aceton, Benzol und Chloroform hat.soluble in ether, acetone, benzene and chloroform.
unlöslich. Man rührt 30 Minuten, versetzt mit 15 ecm Methanolinsoluble. The mixture is stirred for 30 minutes, and 15 ecm of methanol are added
65 und 250 ecm Wasser, kühlt ab und neutralisiert mit65 and 250 ecm of water, cools down and neutralizes with it
Analyse: C23H40O2NJ = 489,47. 880 ecm konzentriertem Ammoniak. Man kühltAnalysis: C 23 H 40 O 2 NJ = 489.47. 880 ecm of concentrated ammonia. One cools
Berechnet ... J25,93%, N2,86%; 1 Stunde, saugt ab, wäscht mit Wasser und trocknetCalculated ... J25.93%, N2.86%; 1 hour, vacuum, wash with water and dry
gefunden ... J25,2%, N2,6%. im Vakuum.found ... J25.2%, N2.6%. in a vacuum.
Man löst das erhaltene Produkt in heißem Äthylacetat, engt ein, kühlt 1 Stunde, saugt ab und wäscht mit Äthylacetat.The product obtained is dissolved in hot ethyl acetate, concentrated, cooled for 1 hour, filtered off with suction and washed with ethyl acetate.
Man erhält 8,33 g S^l-Dioxo^O-methyl^O-dimethylamino-5/9-pregnan (F. = 216°C). [x]! D° = +54,5° ±2° (c = 0,45%, Äthanol), was einer Ausbeute von 57,7% entspricht.8.33 g of S ^ l-dioxo ^ O-methyl ^ O-dimethylamino-5/9-pregnane (mp = 216 ° C.) are obtained. [x] ! D ° = + 54.5 ° ± 2 ° (c = 0.45%, ethanol), which corresponds to a yield of 57.7%.
Das Produkt ergibt sich in Form von farblosen Kristallen, die in Alkohol, Aceton und Chloroform löslich und in Wasser unlöslich sind.The product results in the form of colorless crystals that exist in alcohol, acetone and chloroform are soluble and insoluble in water.
15minutiges Anteigen in 50 ecm siedendem Äthylacetat ergibt 1,07 g des reinen Hydrochlorids, das bei 280 bis 2900C schmilzt.15minutiges pasting in 50 cc of boiling ethyl acetate yields 1.07 g of pure hydrochloride of which melts at 280-290 0 C.
Claims (2)
gefunden ... C77,2%, H 10,3%, N4,0%.Calculated ... C 77.17%, H 10.52%, N 3.75%;
found ... C77.2%, H 10.3%, N 4.0%.
gefunden ... C 77,6%, H 9,7%, N 3,9%.Calculated ... C77.59%, H 10.04%, N 3.76%;
found ... C 77.6%, H 9.7%, N 3.9%.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR907856A FR1421231A (en) | 1962-08-27 | 1962-08-27 | New amino steroids and method of preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1212082B true DE1212082B (en) | 1966-03-10 |
Family
ID=8785774
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DER35991A Pending DE1212081B (en) | 1962-08-27 | 1963-08-27 | Process for the preparation of 11-oxo-20-tert-amino-20-alkyl-5beta-pregnane compounds and salts thereof |
| DER35990A Pending DE1212080B (en) | 1962-08-27 | 1963-08-27 | Process for the preparation of 20-tert-amino-20-alkyl steroids and salts thereof |
| DER35993A Pending DE1212083B (en) | 1962-08-27 | 1963-08-27 | Process for the preparation of 20-tert-amino-20-alkyl-5alpha-pregnane compounds and salts thereof |
| DER35992A Pending DE1212082B (en) | 1962-08-27 | 1963-08-27 | Process for the preparation of 3, 11-Dioxo-20-tert-amino-20-alkyl-4-pregnenverbindungen and salts thereof |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DER35991A Pending DE1212081B (en) | 1962-08-27 | 1963-08-27 | Process for the preparation of 11-oxo-20-tert-amino-20-alkyl-5beta-pregnane compounds and salts thereof |
| DER35990A Pending DE1212080B (en) | 1962-08-27 | 1963-08-27 | Process for the preparation of 20-tert-amino-20-alkyl steroids and salts thereof |
| DER35993A Pending DE1212083B (en) | 1962-08-27 | 1963-08-27 | Process for the preparation of 20-tert-amino-20-alkyl-5alpha-pregnane compounds and salts thereof |
Country Status (6)
| Country | Link |
|---|---|
| BE (1) | BE636641A (en) |
| DE (4) | DE1212081B (en) |
| ES (1) | ES290991A1 (en) |
| FR (3) | FR1421231A (en) |
| GB (4) | GB1025907A (en) |
| NL (4) | NL297131A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3013008A (en) * | 1961-01-09 | 1961-12-12 | Searle & Co | N-substituted 20-aminopregnan-3-ols, esters thereof, and deta-derivatives corresponding |
-
0
- NL NL297135D patent/NL297135A/xx unknown
- NL NL123751D patent/NL123751C/xx active
- BE BE636641D patent/BE636641A/xx unknown
- NL NL297133D patent/NL297133A/xx unknown
- NL NL297131D patent/NL297131A/xx unknown
-
1962
- 1962-08-27 FR FR907856A patent/FR1421231A/en not_active Expired
- 1962-11-27 FR FR916749A patent/FR2374M/en not_active Expired
-
1963
- 1963-05-03 FR FR933624A patent/FR56F/en not_active Expired
- 1963-08-22 ES ES290991A patent/ES290991A1/en not_active Expired
- 1963-08-27 GB GB3393763A patent/GB1025907A/en not_active Expired
- 1963-08-27 GB GB3393863A patent/GB1025908A/en not_active Expired
- 1963-08-27 DE DER35991A patent/DE1212081B/en active Pending
- 1963-08-27 DE DER35990A patent/DE1212080B/en active Pending
- 1963-08-27 DE DER35993A patent/DE1212083B/en active Pending
- 1963-08-27 GB GB3393663A patent/GB1025906A/en not_active Expired
- 1963-08-27 DE DER35992A patent/DE1212082B/en active Pending
-
1965
- 1965-04-14 GB GB1601065A patent/GB1045644A/en not_active Expired
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3013008A (en) * | 1961-01-09 | 1961-12-12 | Searle & Co | N-substituted 20-aminopregnan-3-ols, esters thereof, and deta-derivatives corresponding |
Also Published As
| Publication number | Publication date |
|---|---|
| DE1212081B (en) | 1966-03-10 |
| FR1421231A (en) | 1965-12-17 |
| NL297133A (en) | |
| NL123751C (en) | |
| DE1212083B (en) | 1966-03-10 |
| GB1025907A (en) | 1966-04-14 |
| NL297135A (en) | |
| BE636641A (en) | |
| GB1045644A (en) | 1966-10-12 |
| GB1025908A (en) | 1966-04-14 |
| DE1212080B (en) | 1966-03-10 |
| NL297131A (en) | |
| GB1025906A (en) | 1966-04-14 |
| FR56F (en) | 1964-10-16 |
| ES290991A1 (en) | 1963-12-01 |
| FR2374M (en) | 1964-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2147023A1 (en) | PROCESS FOR PRODUCING 1HTETRAZOLE COMPOUNDS | |
| DE2308305A1 (en) | PROCESS FOR THE PREPARATION OF 4-HYDROXY-3- (5-METHYL-3-ISOXAZOLYLCARBAMOYL) 2-METHYL-2H-1,2-BENZOTHIAZINE-1,1-DIOXIDE | |
| DE1212082B (en) | Process for the preparation of 3, 11-Dioxo-20-tert-amino-20-alkyl-4-pregnenverbindungen and salts thereof | |
| DE909097C (en) | Process for the production of trithions | |
| DE1232577B (en) | Process for the preparation of delta 4,9-3-oxo-11beta-hydroperoxy-19-nor-steroids | |
| DE2166270C3 (en) | Nicotinoylaminoethanesulfonyl-2amino-thiazole | |
| DE1468517B1 (en) | Oestran series steroids and process for their manufacture | |
| DE2225482C3 (en) | Pyrindine-2,6-bis (dithiocarbamate) derivatives, processes for producing the same, and compositions containing the same | |
| DE1072243B (en) | Process for the preparation of water-soluble cortisone derivatives | |
| DE2247828A1 (en) | SULFAMOYL ANTHRANILIC ACIDS AND THE PROCESS FOR THEIR MANUFACTURE | |
| DE1770449C3 (en) | 09/26/67 Japan 61864-67 Process for the preparation of 5,6-dihydro-4H-1,3,4-thiadiazin-5-one derivatives | |
| DE1174797B (en) | Process for the preparation of sulfamylanthranilic acids | |
| DE945237C (en) | Process for the preparation of pyrrolinones | |
| AT274802B (en) | Process for the production of indole derivatives | |
| DE915938C (en) | Process for the preparation of oxoacylamines of the cyclopentanopolyhydrophenanthrene series | |
| DE1468517C (en) | Ostran series steroids and processes for their manufacture | |
| DE1695757C3 (en) | Pyridine methanol carbamates and processes for their preparation | |
| DE2650918C2 (en) | Process for the preparation of N? 1? - (2-tetrahydrofuranyl) -5-fluoro-uracil | |
| DE1543651A1 (en) | Process for the preparation of N, N-di-substituted hydroxylamine-O-alkyl (or alkaryl) sulfonic acids or their salts | |
| DE1235322B (en) | Process for the preparation of 7-oxo-deacetamido-colchicine derivatives | |
| DE2306112A1 (en) | THIOURAL DERIVATIVES OF VITAMIN ASAEURS | |
| DE1055538B (en) | Process for the preparation of basic substituted derivatives of 4-aza-phenthiazines | |
| DE1280859B (en) | Process for the preparation of glycyrrhetinic acid derivatives containing nitro groups | |
| DE2235428B2 (en) | Process for the preparation of 3- (beta-dialkylaminoethyl) -4-alkyl-7-C arboethoxy methoxy coumarins | |
| DE1212955B (en) | Process for the production of basic substituted salicylamide-O-acetic acid esters |